Citations

Showing 10 of 108162 citations.

Dissemination of Gastroenterology and Hepatology Research on Social Media Platforms Is Associated With Increased Citation Count
Ayoub, Fares , Ouni, A. El , Case, Robert , Ladna, Michael , Ouni, Ahmed, Ouni, Ahmed, Shah, Harsh, Rubin, David T.

Mayo Clinic

American Journal of Gastroenterology | March 26, 2021 | Volume: 116 | Issue: 10 | Pages: 2137-2139

10.14309/ajg.0000000000001240 | PMID 33767107 Get It

INTRODUCTION: The purpose of this study was to find out whether dissemination of gastroenterology and hepatology (GI) research on social media networks correlates with citation count at 5 years. METHODS: We correlated the Altmetric Attention Score with Web of Science citation counts at 5 years for scholarly work published in the 10 highest impact factor GI journals in 2014. RESULTS: In 4,026 analyzed items, the correlation ( r ) between Altmetric Attention Score and citations at 5 years was 0.62 ( P < 0.001), representing strong correlation. Twitter was the platform with the strongest correlation with citations. DISCUSSION: Social media attention garnered by GI scholarly work strongly correlates with the number of citations at 5 years.
Go With the Flow: Alternative Terminology in Relational Anatomy
Thomas, Maria C., Chang, Enchi K. , Petersen, Bret T. , Petersen, Bret T. , Bazerbachi, Fateh

Mayo Clinic

American Journal of Gastroenterology | March 26, 2021 | Volume: 116 | Issue: 8 | Pages: 1764-1764

10.14309/ajg.0000000000001252 | PMID 33767106 Get It

Controversies in Gastroparesis: Discussing the Sticky Points
Lacy, Brian E. , Cangemi, David J. , Lacy, Brian E.

Mayo Clinic

American Journal of Gastroenterology | March 26, 2021 | Volume: 116 | Issue: 8 | Pages: 1572-1576

10.14309/ajg.0000000000001243 | PMID 33767098 Get It

Thromboembolic Disease in COVID-19
Tarmey, Tara, Cullen, Grace , Patel, Tanay Y., Tandon, Yasmeen K. , Tandon, Yasmeen Kour, Cullen, Grace D

Mayo Clinic

Journal of Clinical Imaging Science | March 26, 2021 | Volume: 11 | Issue: No issue available | Pages: 16

10.25259/jcis_108_2020 | PMID 33880241 Get It

Coronavirus disease 2019 (COVID-19) was initially recognized in late December 2019 and has quickly spread globally with over 114 million reported cases worldwide at the time of this publication. For the majority of patients infected with COVID-19, the clinical manifestations are absent or mild. In more advanced cases, severe respiratory dysfunction is the leading cause of morbidity and mortality. However, increasingly, there have been reports of increased thrombotic complications including pulmonary embolism and deep vein thrombosis seen in these patients. We present herein a series of cases of concomitant COVID-19 pneumonia and venous thromboembolism. These cases highlight the importance of clinical and radiologic vigilance to ensure this often clinically silent complication is not missed.
Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer
Archambault, Alexi , Jeon, Jihyoun , Harrison, Tabitha A. , Bishop, D. Timothy , Brenner, Hermann , Casey, Graham , Chang‐Claude, Jenny , Figueiredo, Jane C. , Gallinger, Steven , Gruber, Stephen B. , Gunter, Marc J. , Hoffmeister, Michael , Li, Li , Pai, Rish K. , Parfrey, Patrick S. , Rennert, Gad , Sandler, Robert S. , Slattery, Martha L. , Song, Mingyang , Win, Aung Ko , Woods, Michael O. , Murphy, Neil , Zeleniuch‐Jacquotte, Anne , Liang, Peter S. , Du, Mengmeng , Peters, Ulrike , Hayes, Richard B. , Archambault, Alexi N , Jeon, Jihyoun , Harrison, Tabitha A , Bishop, D Timothy , Brenner, Hermann , Chang-Claude, Jenny , Figueiredo, Jane C , Gruber, Stephen B , Gunter, Marc J , Hoffmeister, Michael , Jenkins, Mark A , Moreno, Victor , Pai, R K , Rennert, Gad , Sakoda, Lori C , Song, Mingyang , Win, Aung K , Woods, Michael O , Campbell, Peter T , Liang, Peter S , Hayes, Richard B , Murphy, Neil , Sandler, Robert S , Zeleniuch-Jacquotte, Anne , Lin, Yi , Chan, Andrew T. , Jenkins, Mark A. , Keku, Temitope O , Marchand, Loı̈c Le , Moreno, Vı́ctor , Newcomb, Polly A. , Sakoda, Lori C. , Campbell, Peter T. , Su, Yu-Ru

Mayo Clinic

JNCI Cancer Spectrum | March 26, 2021 | Volume: 5 | Issue: 3 | Pages: No page available

10.1093/jncics/pkab029 | PMID 34041438 Get It

Abstract Background Incidence of early-onset (younger than 50 years of age) colorectal cancer (CRC) is increasing in many countries. Thus, elucidating the role of traditional CRC risk factors in early-onset CRC is a high priority. We sought to determine whether risk factors associated with late-onset CRC were also linked to early-onset CRC and whether association patterns differed by anatomic subsite. Methods Using data pooled from 13 population-based studies, we studied 3767 CRC cases and 4049 controls aged younger than 50 years and 23 437 CRC cases and 35 311 controls aged 50 years and older. Using multivariable and multinomial logistic regression, we estimated odds ratios (ORs) and 95% confidence intervals (CIs) to assess the association between risk factors and early-onset CRC and by anatomic subsite. Results Early-onset CRC was associated with not regularly using nonsteroidal anti-inflammatory drugs (OR = 1.43, 95% CI = 1.21 to 1.68), greater red meat intake (OR = 1.10, 95% CI = 1.04 to 1.16), lower educational attainment (OR = 1.10, 95% CI = 1.04 to 1.16), alcohol abstinence (OR = 1.23, 95% CI = 1.08 to 1.39), and heavier alcohol use (OR = 1.25, 95% CI = 1.04 to 1.50). No factors exhibited a greater excess in early-onset compared with late-onset CRC. Evaluating risks by anatomic subsite, we found that lower total fiber intake was linked more strongly to rectal (OR = 1.30, 95% CI = 1.14 to 1.48) than colon cancer (OR = 1.14, 95% CI = 1.02 to 1.27; P = .04). Conclusion In this large study, we identified several nongenetic risk factors associated with early-onset CRC, providing a basis for targeted identification of those most at risk, which is imperative in mitigating the rising burden of this disease.
IVIG and Small Fiber Neuropathy
Gibbons, Christopher H. , Klein, Christopher J.

Mayo Clinic

Neurology | March 25, 2021 | Volume: 96 | Issue: 20 | Pages: 929-930

10.1212/wnl.0000000000011921 | PMID 33766998 Get It

Where in the World Have All the Strokes Gone?
Demaerschalk, Bart M. , Demaerschalk, Bart M

Mayo Clinic

Neurology | March 25, 2021 | Volume: 96 | Issue: 23 | Pages: 1069-1070

10.1212/wnl.0000000000011886 | PMID 33766991 Get It

A Technical Nuance to Avoid Lumbar Five Radiculopathy with Anterior Lumbar Fusion and Posterior Instrumentation
Neal, Matthew T. , Kalani, Maziyar A. , Lyons, Mark , Lyons, Mark K

Mayo Clinic

Case Reports in Orthopedics | March 25, 2021 | Volume: 2021 | Issue: No issue available | Pages: 1-4

10.1155/2021/5514720 | PMID 33833886 Get It

The anterior lumbar interbody fusion (ALIF) is a well-established procedure used to treat a multitude of spinal pathologies. When performed at the L5-S1 level, the ALIF is often supplemented with posterior pedicle screw and rod fixation. Because the interbody device can restore disk and foraminal height, one benefit of the ALIF procedure is indirect neural decompression in the spinal canal and neural foramina. If the contour of the posterior rod is not matched to the exact position of the tulip heads on the pedicle screws, spondylolisthesis can be introduced, leading to foraminal stenosis and nerve compression. This concern is particularly germane when the posterior instrumentation is placed percutaneously without any direct foraminal decompression. In this report, we describe a patient who had an L4-S1 ALIF, resulting in new L5-S1 retrolisthesis and worsening L5 radiculopathy. Technical nuances and avoidance strategies are discussed.
Revision Reverse Shoulder Arthroplasty for Anatomical Glenoid Component Loosening Was Not Universally Successful
Bartels, D , Marigi, Erick M. , Sperling, John W. , Sánchez‐Sotelo, Joaquín , Bartels, Douglas W , Marigi, Erick , Sanchez-Sotelo, J.

Mayo Clinic

Journal of Bone and Joint Surgery | March 25, 2021 | Volume: 103 | Issue: 10 | Pages: 879-886

10.2106/jbjs.20.00555 | PMID 33764935 Get It

Background: Glenoid component loosening is a primary cause of failure of anatomical total shoulder arthroplasty (TSA) and is commonly associated with glenoid bone loss. The purpose of the present study was to evaluate the outcome and survival following revision to a reverse total shoulder arthroplasty (RSA) for the treatment of loosening of a polyethylene cemented glenoid component in the setting of failed TSA. Methods: Between 2010 and 2017, 151 shoulders underwent revision to RSA for the treatment of loosening of an anatomical polyethylene glenoid component. Shoulders with staged reconstruction for the treatment of infection were excluded. One hundred and twenty-seven patients (67 women and 60 men) had a single-stage reconstruction and were available for follow-up. The mean age at the time of surgery was 70 years (range, 41 to 93 years). In all cases, the humeral component was revised and a standard glenoid baseplate was utilized. Bone graft was used at the discretion of the treating surgeon. Medical records and radiographs were reviewed to collect demographic, intraoperative, and postoperative data; to quantify glenoid bone loss; and to determine the radiographic outcome. The mean duration of follow-up was 35 months (range, 24 to 84 months). Results: Revision to RSA resulted in significant improvements in terms of pain and motion. Sixteen shoulders (13%) underwent revision surgery for the treatment of baseplate loosening. Radiographic baseplate loosening was present in 6 additional shoulders (overall rate of baseplate loosening, 17%). Intraoperative fracture or fragmentation of the greater tuberosity occurred in 30 shoulders (24%). Other reoperations included resection for deep infection (3 shoulders), arthroscopic biopsies for unexplained persistent pain (2 shoulders), humeral tray exchange for dislocation (2 shoulders), revision for humeral loosening (1 shoulder), irrigation and debridement for hematoma (1 shoulder), and internal fixation of periprosthetic fracture (1 shoulder) (overall reoperation rate, 20%). Among shoulders with surviving implants at the time of the most recent follow-up, pain was rated as none or mild in 83 shoulders (65.4%) and the average active elevation and external rotation were 132° and 38°, respectively. With the numbers available, no risk factors for failure could be identified. Conclusions: Revision RSA for the treatment of loosening of an anatomical polyethylene component was associated with a 17% glenoid mechanical failure rate. Although this procedure resulted in improvements in terms of pain and function, it was not universally successful and thus needs further refinement in order to improve outcomes. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)
Harrison, Michael R. , Costello, Brian A. , Vaishampayan, Ulka N. , Pal, Sumanta K. , Zakharia, Yousef , Jim, Heather , Fishman, Mayer , Molina, Ana M. , Kyriakopoulos, Christos E. , Tsao, Che‐Kai, Gartrell, Benjamin A. , Hussain, Arif , Agarwal, Neeraj , Pachynski, Russell K. , Hammers, Hans J. , Ryan, Christopher W. , Inman, Brant A. , Mardekian, Jack , Borham, Azah, George, Daniel J. , Pal, Sumanta K , Jim, Heather S L , Stadler, Walter M , Inman, Brant A , Vaishampayan, Ulka , Pachynski, Russell K , Zakharia, Yousef , Bhavsar, Nrupen Anjan , Appleman, Leonard J. , Stadler, Walter M. , Agarwal, Neeraj , Hutson, Thomas E.

Mayo Clinic

Cancer | March 25, 2021 | Volume: 127 | Issue: 13 | Pages: 2204-2212

10.1002/cncr.33494 | PMID 33765337 Get It

BackgroundSystemic therapy (ST) can be deferred in patients who have metastatic renal cell carcinoma (mRCC) and slow‐growing metastases. Currently, this subset of patients managed with active surveillance (AS) is not well described in the literature.MethodsThis was a prospective observational study of patients with mRCC across 46 US community and academic centers. The objective was to describe baseline characteristics and demographics of patients with mRCC initially managed by AS, reasons for AS, and patient outcomes. Descriptive statistics were used to characterize demographics, baseline characteristics, and patient‐related outcomes. Wilcoxon 2‐sample rank‐sum tests and χ2 tests were used to assess differences between ST and AS cohorts in continuous and categorical variables, respectively. Kaplan‐Meier survival curves were used to assess survival.ResultsOf 504 patients, mRCC was initially managed by AS (n = 143) or ST (n = 305); 56 patients were excluded from the analysis. Disease was present in 69% of patients who received AS, whereas the remaining 31% had no evidence of disease. At data cutoff, 72 of 143 patients (50%) in the AS cohort had not received ST. The median overall survival was not reached (95% CI, 122 months to not estimable) in patients who received AS versus 30 months (95% CI, 25‐44 months) in those who received ST. Quality of life at baseline was significantly better in patients who were managed with AS versus ST.ConclusionsAS occurs frequently (32%) in real‐world clinical practice and appears to be a safe and appropriate alternative to immediate ST in selected patients.